Real-Time Continuous Glucose Monitoring Benefits Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes Irrespective of Insulin Delivery Modality: Subanalysis of the MILLENNIAL Study

J Diabetes Sci Technol. 2022 Jan;16(1):252-253. doi: 10.1177/19322968211029627. Epub 2021 Oct 9.

Authors

Ik Hur Teoh¹, Joshi Prabhu¹, Womba Mubita¹, Shazli Azmi^{1

2}, Andrea Urwin¹, Ian Doughty³, Lalantha Leelarathna^{1

2}, Hood Thabit^{1

2}

Affiliations

¹ Diabetes, Endocrine and Metabolism Centre, Manchester Royal Infirmary, Manchester, UK.
² Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
³ Royal Manchester Children's Hospital, Manchester Royal Infirmary, Manchester, UK.

No abstract available

Keywords: adolescents; glucose sensors; insulin pump; multiple daily injections; real-time glucose monitoring; type 1 diabetes; young adults.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1* / drug therapy
Glycated Hemoglobin / analysis
Glycemic Control
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin Infusion Systems
Young Adult

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
Insulin